New Delhi, May 17 -- GLP-1 analogues have revolutionised the management of obesity and type 2 diabetes; however, health experts say that they come with real risks and limitations that patients should be aware of. In an interview with HT Lifestyle, Dr Jaison Paul Sharma, MBBS, MD (Internal Medicine) - consultant diabetologist at Sharma Hospital in Garhdiwala, revealed that "common side effects include nausea, bloating, constipation and other gastrointestinal issues."

Dr Jaison Paul Sharma shared, "These medications are expensive, often not covered by insurance and unsustainable for long-term use. Rapid weight loss without adequate nutrition can lead to a reduction in lean muscle mass, and many patients experience rebound weight gain once ...